News

/News

Cyclotron Arrival at Translational Imaging Center Announced by CRO Partnership

Particle accelerator will produce radioisotopes for tagging and tracking potential new drugs starting this spring

Mattawan, MICH., February 26, 2014 – MPI Research Chairman and CEO William U. Parfet, Jack Hoppin, PhD, Co-Founder, and Managing Partner of inviCRO, and Marc Berridge, PhD, President, and Founder of 3D Imaging today announced the arrival of one of the most […]

By |2017-07-04T10:27:54+00:00February 26th, 2014|News|Comments Off on Cyclotron Arrival at Translational Imaging Center Announced by CRO Partnership

Translational Imaging Center to Speed Drug Development, Lower Costs

First-of-its-Kind Facility to Begin Operations in Early Spring

Mattawan, MICH. – MPI Research, inviCRO, and 3D Imaging today formally announced the name of their new advanced imaging center being built at the MPI Research headquarters in Mattawan, Mich. A joint partnership by the three organizations, the Translational Imaging Center, is the first resource for the drug […]

By |2017-07-04T10:27:58+00:00February 6th, 2014|News|Comments Off on Translational Imaging Center to Speed Drug Development, Lower Costs

First to Validate

Leading the Way for Biomarker Sample Analysis for Proinflammatory Cytokines in Mice Using MSD® V-PLEX Immunoassays

MPI Research has successfully completed validation of the newest multiplex option from Meso Scale Discovery® (MSD) for proinflammatory cytokines in mouse samples, the V-PLEX™ Proinflammatory Panel 1 (mouse). As the first contract research organization (CRO) to validate this multiplexed assay, […]

By |2017-07-04T10:28:03+00:00October 25th, 2013|News|Comments Off on First to Validate

MPI Research Breaks Ground on New World-class Imaging Center

Partnership with INVICRO and 3D Imaging will provide drug developers with the world’s first commercially available cyclotron offering contiguous on-site vivarium facilities.

Mattawan, Mich. (Sept. 6, 2013) – MPI Research, in partnership with INVICRO and 3D Imaging, today held […]

By |2017-07-04T10:28:08+00:00September 6th, 2013|News|Comments Off on MPI Research Breaks Ground on New World-class Imaging Center

MPI Research, inviCRO, and 3D Imaging Announce Strategic Partnership

MPI Research, the largest single-site preclinical/early clinical contract research organization (CRO) globally, is pleased to announce a strategic partnership with inviCRO and 3D Imaging to unite world-class molecular imaging, radiochemistry, and informatics to accelerate drug discovery and development. This partnership represents a combination of integrated imaging solutions that is offered by no other CRO in […]

By |2017-07-04T10:28:17+00:00June 17th, 2013|News|Comments Off on MPI Research, inviCRO, and 3D Imaging Announce Strategic Partnership

How to Raise Medical Device Startup Funding in a Harsh Investment Climate

Universities and entrepreneurs are continually developing new innovations in the world of medical devices and diagnostics, but the 2008 economic crash, investor consolidation, and increased investor wariness have made funding for those ideas much harder to secure. Even before 2008, traditional venture funding for these projects was deteriorating, and purse strings have remained somewhat tight […]

By |2014-03-17T14:53:43+00:00May 28th, 2013|News|Comments Off on How to Raise Medical Device Startup Funding in a Harsh Investment Climate

MPI Research Announces New Division

MPI Research, the largest single-site preclinical contract research organization (CRO) worldwide, has created a new division, Surgical Services and Medical Device Evaluation (SMD), which will be led by Senior Director Mark Johnson, MS. As a Senior Study Director with more than 15 years of GLP and non-GLP experience specifically in this field, Mr. Johnson leads […]

By |2017-07-04T10:28:22+00:00May 24th, 2013|News|Comments Off on MPI Research Announces New Division

Directions in Discovery and Development

Pharmaceutical, biotechnology, food, environmental, and chemical companies are all challenged by the same expectations when they partner with a laboratory to do their bioanalytical, analytical, and environmental testing: depth and breadth of expertise, scope of services, accuracy and speed of results and reporting, quality, efficiency and regulatory knowledge of the staff. Our customers, be they […]

By |2017-07-04T10:28:27+00:00April 29th, 2013|News|Comments Off on Directions in Discovery and Development

Innovative Assays for Alzheimer’s Disease

MPI Research, the largest single-site preclinical contract research organization worldwide, is pleased to announce that it recently completed specialized training from Meso Scale Discovery (MSD) to run Ab42 and Total Tau immunoassays on the MSD Imager platform. MPI Research is setting the pace for providing knowledge and expertise needed by our Sponsors as they develop […]

By |2017-07-04T10:28:45+00:00January 17th, 2013|News|Comments Off on Innovative Assays for Alzheimer’s Disease

Our New Website

As we move into the New Year, we invite you to visit our refreshed website to learn how MPI Research can go beyond for you. The depth and breadth of our experienced scientific team at MPI Research is the reason many Sponsors select us as their preferred provider for their preclinical, early […]

By |2017-07-04T10:28:49+00:00January 2nd, 2013|News|Comments Off on Our New Website